z-logo
open-access-imgOpen Access
Combination therapies with mitogen-activated protein kinase kinase inhibitors and immune checkpoint inhibitors in non-small cell lung cancer
Author(s) -
Jiali Xu,
Xinzhu Wang,
Huning Jiang,
Yi Chen,
Rong Wang,
Yongqian Shu
Publication year - 2020
Publication title -
chinese medical journal/chinese medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.537
H-Index - 63
eISSN - 2542-5641
pISSN - 0366-6999
DOI - 10.1097/cm9.0000000000001070
Subject(s) - mapk/erk pathway , kras , protein kinase a , cancer research , mek inhibitor , medicine , kinase , lung cancer , targeted therapy , melanoma , carcinogenesis , cancer , biology , microbiology and biotechnology , oncology , colorectal cancer

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here